Middle east respiratory syndrome coronavirus (MERS-CoV)

Clinical trials for Middle east respiratory syndrome coronavirus (MERS-CoV) explained in plain language.

Never miss a new study

Get alerted when new Middle east respiratory syndrome coronavirus (MERS-CoV) trials appear

Sign up with your email to follow new studies for Middle east respiratory syndrome coronavirus (MERS-CoV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New DNA vaccine shows promise against deadly MERS virus

Vaccine Completed

This Phase 2 trial tested a new DNA vaccine called INO-4700 in 192 healthy adults to see if it is safe and can trigger an immune response against MERS, a serious coronavirus. The vaccine is given as a shot under the skin followed by a quick electric pulse to help cells take up th…

Matched conditions: MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV)

Phase 2 • Sponsor: Inovio Pharmaceuticals • Aim: Vaccine

Last updated Jun 27, 2026 08:12 UTC

Middle east respiratory syndrome coronavirus (MERS-CoV)

Get alerted when new Middle east respiratory syndrome coronavirus (MERS-CoV) trials appear

New DNA vaccine shows promise against deadly MERS virus